This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Weeks, B. H. Articles by Wang, X.-J. Search for Related Content PubMed PubMed Citation Articles by Weeks, B. H. Articles by Wang, X.-J.

Inducible Expression of Transforming Growth Factor ß1 in Papillomas Causes Rapid Metastasis¹

Departments of Otolaryngology [B. H. W., K. L. O.], Dermatology [W. H., X-J. W.], and Molecular and Cellular Biology [X-J. W.], Baylor College of Medicine, Houston, Texas 77030

Transforming growth factor ß1 (TGF-ß1) acts as a tumor suppressor at early stages of carcinogenesis, however, it has also been suggested to promote tumor progression at late stages. To determine at which stage and by what mechanisms this functional switch occurs, we have generated gene-switch-TGF-ß1 mice in which TGF-ß1 transgene expression can be induced in skin tumors at specific stages. These mice were exposed to a chemical carcinogenesis protocol, which allows tumorigenesis to develop in progressive stages from benign papillomas to malignant carcinomas. Remarkably, TGF-ß1 transgene induction in papillomas rapidly induced metastasis. This function is in sharp contrast to its tumor suppressive effect when TGF-ß1 transgene expression was induced early in the protocol. Transgenic papillomas exhibited down-regulation of TGF-ß receptors and their signal transducer, the Smads, and loss of the invasion suppressor E-cadherin/catenin complex in the cell membrane. These molecules were lost only in malignant carcinomas in control mice at a much later stage. Furthermore, transgenic papillomas exhibited elevated expression of matrix metalloproteinases and increased angiogenesis. Our study suggests that TGF-ß1 overexpression may directly induce tumor metastasis by initiating events necessary for invasion. Down-regulation of TGF-ß signaling components in tumor epithelia selectively abolishes growth inhibition, thus, switching the role of TGF-ß1 to a metastasis promoter.

This article has been cited by other articles:

				A. B. Glick, R. Perez-Lorenzo, and J. Mohammed Context-dependent regulation of cutaneous immunological responses by TGF{beta}1 and its role in skin carcinogenesis Carcinogenesis, January 1, 2008; 29(1): 9 - 14. [Abstract] [Full Text] [PDF]

				M. D. Lacher, M. I. Tiirikainen, E. F. Saunier, C. Christian, M. Anders, M. Oft, A. Balmain, R. J. Akhurst, and W. M. Korn Transforming Growth Factor-{beta} Receptor Inhibition Enhances Adenoviral Infectability of Carcinoma Cells via Up-Regulation of Coxsackie and Adenovirus Receptor in Conjunction with Reversal of Epithelial-Mesenchymal Transition Cancer Res., February 1, 2006; 66(3): 1648 - 1657. [Abstract] [Full Text] [PDF]

				M H Barcellos-Hoff How tissues respond to damage at the cellular level: orchestration by transforming growth factor-{beta} (TGF-{beta}) Br. J. Radiol., January 1, 2005; Supplement_27(1): 123 - 127. [Abstract] [Full Text] [PDF]

				R. S. Muraoka-Cook, H. Kurokawa, Y. Koh, J. T. Forbes, L. R. Roebuck, M. H. Barcellos-Hoff, S. E. Moody, L. A. Chodosh, and C. L. Arteaga Conditional Overexpression of Active Transforming Growth Factor {beta}1 In vivo Accelerates Metastases of Transgenic Mammary Tumors Cancer Res., December 15, 2004; 64(24): 9002 - 9011. [Abstract] [Full Text] [PDF]

				A. G. Li, S.-L. Lu, M.-X. Zhang, C. Deng, and X.-J. Wang Smad3 Knockout Mice Exhibit a Resistance to Skin Chemical Carcinogenesis Cancer Res., November 1, 2004; 64(21): 7836 - 7845. [Abstract] [Full Text] [PDF]

				H. G. Munshi, Y. I. Wu, S. Mukhopadhyay, A. J. Ottaviano, A. Sassano, J. E. Koblinski, L. C. Platanias, and M. S. Stack Differential Regulation of Membrane Type 1-Matrix Metalloproteinase Activity by ERK 1/2- and p38 MAPK-modulated Tissue Inhibitor of Metalloproteinases 2 Expression Controls Transforming Growth Factor-{beta}1-induced Pericellular Collagenolysis J. Biol. Chem., September 10, 2004; 279(37): 39042 - 39050. [Abstract] [Full Text] [PDF]

				S.-L. Lu, D. Reh, A. G. Li, J. Woods, C. L. Corless, M. Kulesz-Martin, and X.-J. Wang Overexpression of Transforming Growth Factor {beta}1 in Head and Neck Epithelia Results in Inflammation, Angiogenesis, and Epithelial Hyperproliferation Cancer Res., July 1, 2004; 64(13): 4405 - 4410. [Abstract] [Full Text] [PDF]

				S. E. Seton-Rogers, Y. Lu, L. M. Hines, M. Koundinya, J. LaBaer, S. K. Muthuswamy, and J. S. Brugge Cooperation of the ErbB2 receptor and transforming growth factor {beta} in induction of migration and invasion in mammary epithelial cells PNAS, February 3, 2004; 101(5): 1257 - 1262. [Abstract] [Full Text] [PDF]

				M. Mareel and A. Leroy Clinical, Cellular, and Molecular Aspects of Cancer Invasion Physiol Rev, April 1, 2003; 83(2): 337 - 376. [Abstract] [Full Text] [PDF]

				Y. Guo, A. P. Mazar, J.-J. Lebrun, and S. A. Rabbani An Antiangiogenic Urokinase-derived Peptide Combined with Tamoxifen Decreases Tumor Growth and Metastasis in a Syngeneic Model of Breast Cancer Cancer Res., August 15, 2002; 62(16): 4678 - 4684. [Abstract] [Full Text] [PDF]